chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received vaccines at approximately 1:45pm. Mother reports "Child got really quick in back seat of car, mom turned to check on him , his face was "frozen" and solid, he could move left side at all-Right side seemed fine to her. Had 2 seizures - first was at 2:55 pm" Patient was seen at the ER, given TYLENOL. Labs were done and observed. Patient didn't have a temperature at ER. Patient was discharged from ER, with appointment to see a physician  for EEG on 2/3/09.
Hot to touch injection site; Rash at the injection site; Red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to touch injection site), VACCINATION SITE RASH (Rash at the injection site) and INJECTION SITE ERYTHEMA (Red at the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011520A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot to touch injection site), VACCINATION SITE RASH (Rash at the injection site) and INJECTION SITE ERYTHEMA (Red at the injection site). At the time of the report, VACCINATION SITE WARMTH (Hot to touch injection site), VACCINATION SITE RASH (Rash at the injection site) and INJECTION SITE ERYTHEMA (Red at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Systemic: Fainting / Unresponsive-Mild, Additional Details: Customer  passed out after the shot. She got her consciouness back in few seconds.Customer refused to get medical attention.
52 M with h/o HTN, DM2 diet controlled, previously on metformin, HLD, fatty liver, childhood asthma, OSA on intermittent CPAP, vaccinated J&J 3/24/21 with SOB/fever after trip to another state, Sx onset 8/24, Covid+ 8/24 with at home kit, confirmed 8/31 KH lab. 93% on RA in ED with tachypnea.    Covid Pneumonia: pt was started and completed a course of Remdesivir 8/31-9/4 and Decadron 6 mg 8/31 which was tapered to 4 mg on discharge and he was discharged on a tapering course. He improved slowly throughout the course of his stay, with sats dropping with ambulation to 89%. Thus pt was prescribed Home O2 for exertion.    DM2: pt was not on any DM meds prior to admission, metformin, previously prescribed had been discontinued. His blood sugars were elevated on decadron and he required a sliding scale for coverage. He was taught on insulin administration and will continue that at home, it is expected his blood sugars will decrease as his decadron dosing decreases.   Hx HTN: pt has a h/o HTN on chlorthalidone, losartan and amlodipine. Chlorthalidone and losartan were held and he was maintained on amlodpine and normotensive. Thus he will not resume chlorthalidone or losartan until f/u with PMD pending his blood pressure trends.     Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  Covid Pneumonia
After waiting  20 minutes, noted some back pain,  tightness; on oxygen at home; cannister almost empty. VSS ; uncertain after  called about whether to be evaluated/go home; refused ED at that time.  Decided if could get in car comfortably would go home, if not, to ED for evaluation. More chest tightness as tried to get in car, decided to go to ED for evaluation; again called.
Peripheral neuropathy; Metallic taste; Shortness of breath; Tingling in hands and feet; Nausea; Headache; Light sensitivity; Numbness; Permanent nerve damage; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NEUROPATHY PERIPHERAL (medically significant), outcome "unknown", described as "Peripheral neuropathy"; DYSGEUSIA (non-serious), outcome "unknown", described as "Metallic taste"; DYSPNOEA (non-serious), outcome "unknown", described as "Shortness of breath"; PARAESTHESIA (non-serious), outcome "unknown", described as "Tingling in hands and feet"; NAUSEA (non-serious), outcome "unknown"; HEADACHE (non-serious), outcome "unknown"; PHOTOSENSITIVITY REACTION (non-serious), outcome "unknown", described as "Light sensitivity"; HYPOAESTHESIA (non-serious), outcome "unknown", described as "Numbness"; NERVE INJURY (non-serious), outcome "unknown", described as "Permanent nerve damage". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I had arm pit swelling with a feeling of fullness. My right breast was larger kinda like filling the cup up and overflowing.
Area is hard; Red area all over deltoid/red area around vaccination site; Area is sore; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE INDURATION (Area is hard), VACCINATION SITE ERYTHEMA (Red area all over deltoid/red area around vaccination site) and VACCINATION SITE PAIN (Area is sore) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 23-Feb-2021, the patient experienced VACCINATION SITE INDURATION (Area is hard), VACCINATION SITE ERYTHEMA (Red area all over deltoid/red area around vaccination site) and VACCINATION SITE PAIN (Area is sore).   At the time of the report, VACCINATION SITE INDURATION (Area is hard), VACCINATION SITE ERYTHEMA (Red area all over deltoid/red area around vaccination site) and VACCINATION SITE PAIN (Area is sore) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Post vax, the pt complained of pain to left upper arm. No fever, but given Advil right away per parent. 6 1/2 x 7 1/2 cm area of erythema and induration. Not tender. No streaking. Treated with cold compresses.
I had shaking Chills, Headache, Fever to 100.7, Eye Pain and extreme fatigue.  These were the exact symptoms that I had when I had Covid in March.  The symptoms lasted for 24 hours then resolved.  I took two doses of Motrin 600mg and spent the day in bed.  Not sure I want the second shot now that I had symptoms similar to my original infection
Rotarix dose via IM instead of oral; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate route of vaccination in a 5-month-old male patient who received Rota (Rotarix lyophilized formulation) (batch number 7S55T, expiry date 7th September 2021) for prophylaxis.   Co-suspect products included rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator (batch number 7S55T, expiry date 7th September 2021) for prophylaxis.   On 21st June 2021, the patient received the 1st dose of Rotarix lyophilized formulation (intramuscular) and Rotarix Oral Applicator Device. On 21st June 2021, unknown after receiving Rotarix lyophilized formulation and Rotarix Oral Applicator Device, the patient experienced inappropriate route of vaccination. On an unknown date, the outcome of the inappropriate route of vaccination was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: On 21st June 2021, the patient received a Rotarix dose via IM instead of oral, wrong route of administration occurred which led to inappropriate route of vaccination. The reporter consented to follow up.
His muscles were hurting a little bit but not much; sleepy; there was pain where he took the COVID 19 vaccine in his left arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYALGIA (non-serious) with onset 23Mar2021, outcome "recovering", described as "His muscles were hurting a little bit but not much"; SOMNOLENCE (non-serious) with onset 23Mar2021, outcome "unknown", described as "sleepy"; VACCINATION SITE PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "there was pain where he took the COVID 19 vaccine in his left arm". Additional information: The patient was scheduled to receive the second dose on 02Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Acute febrile illness, r/o sepsis r/o pacemaker site infection. COVID-19 test negative, CXR clear. Hospitalized and treated with vancomycin/Zosyn. Presents with fever 101.1 F, platelets 98.
In May of 2022, pt was given a dose of Quadracel vaccine, which is not appropriate for this age. Pt had no immediate or long term reaction observed. This event was only discovered when pt transferred to another clinic and staff was reviewing vaccination records.
47yo male for witnessed pre-syncopal episode. Patient reports onset symptoms several minutes after receiving first dose of COVID-19 vaccination. Sat in observation area and shortly after began to feel hot and sweaty, followed by paresthesia in bilateral fingers moving up both extremities. He moved to sit on the ground and his limbs started trembling. Per witnesses on scene no LOC or post ictal state. Patient remembers entire event. Denies feeling anxious about vaccination, stood in line for approximately 10 minutes prior to injection. Denies HA, dysphagia, chest pain, SOB, abdominal pain, N/V/D, dysuria. Prior similar reaction to yellow fever vaccine.
A physician reported that a 51 year old female received Pnu-Imune 23 and influenza virus vaccine on 10/15/99. On 10/17/99, the pt developed an injection site reaction characterized by redness, pain which radiated to the shoulder and elbow and an area of swelling described as the size of a "baseball". She also developed a low-grade fever of 99.8 to 100.0F. She was treated with ibuprofen and Benadryl. This report was received on 10/18/99; the pt had been stable for 1 day. Additional information received from the provider on 2/14/00, stated that the pt recovered.
Muscle infection; blister came out on 5/16/2021. Doctor gave cephalexin 500mg three times a day for 7 days.
pt exp soreness @ inject site p/receiving Typhoid vax; In addition, devel a fever 2 days p/vax which lasted 1 wk;
DTap, IPV (R thigh) Pedvax, PCV- given (L thigh) on 02/06/2002. Pt's mom called next am stating that the child has moderately high temp 103 deg. F. crying non-stop evening after the injections. Also noted swelling and redness at the right thigh.
Constant pain in left arm, trouble laying or sleeping on left arm; frequency increasing, getting worse; has trouble getting shirt on/off-limited mobility with that arm. Patient has not seen a doctor. Everything started after receiving vaccine per patient.
A pharmacist reported that his infant son received his second dose of Prevnar along with DTP (manufacturer unknown) on an unspecified date at approximately 4 months of age. The infant's medical history includes a milk protein allergy and rectal bleeding. The infant was treated with Motrin (ibuprofen) to prevent any pain associated with
I was in bed all day; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (I was in bed all day) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (I was in bed all day). At the time of the report, FATIGUE (I was in bed all day) outcome was unknown.            No concomitant medications reported. No treatment information was reported.  Action taken with mRNA-1273 in response to the event was not applicable.
I had facial fillers. I had a reaction 4 hrs later; My lips swelled up; My cheeks swelled up, Everything on my face just blew up; hard to open my mouth; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE REACTION (I had facial fillers. I had a reaction 4 hrs later), LIP SWELLING (My lips swelled up), SWELLING FACE (My cheeks swelled up, Everything on my face just blew up) and TRISMUS (hard to open my mouth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer Covid-19 booster (Booster) on 17-Jan-2022. Past adverse reactions to the above products included No adverse event with Pfizer Covid-19 booster.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced INJECTION SITE REACTION (I had facial fillers. I had a reaction 4 hrs later), LIP SWELLING (My lips swelled up), SWELLING FACE (My cheeks swelled up, Everything on my face just blew up) and TRISMUS (hard to open my mouth). In 2021, INJECTION SITE REACTION (I had facial fillers. I had a reaction 4 hrs later), LIP SWELLING (My lips swelled up), SWELLING FACE (My cheeks swelled up, Everything on my face just blew up) and TRISMUS (hard to open my mouth) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment  medications were reported. Patient call her cosmetic surgeon on 14-Mar-2022 and did not get a call back.
I had the shot, I was having off and on chills, the next morning I ran a slight fever, I got diarrhea.  I am diabetic insulin dependent for 41 years. I went to the doctor, she sent a prescription for Immodium AD, but I didn't take it. I didn't feel good that day. The doctor told me to get Powerade with electrolytes. Blood sugar was crazy all day. My stomach hurt bad yesterday. I ate peppermint candy as a home remedy and it stopped my pain. I stopped drinking Propel and Vitamin water and went back to 7-up Zero and Sprite. The fever is gone.
Chest pain/pressure, treated with Aspirin 324 mg PO with no change.
Severe vertigo with onset approximately 8 hours after injection. Mild fever symptoms but temperature wasn't measured. Lethargy and weakness accompanied other symptoms. Symptoms cleared after 48 hours.
It was reported that the patient got the COVID shot several months back and it affected another syndrome which she was having and; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (It was reported that the patient got the COVID shot several months back and it affected another syndrome which she was having and) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TREPROSTINIL DIOLAMIN (ORENITRAM) for Pulmonary arterial hypertension.    Concurrent medical conditions included Pulmonary arterial hypertension since 24-Oct-2019. Concomitant products included RIOCIGUAT (ADEMPAS) and DILTIAZEM HYDROCHLORIDE for Pulmonary arterial hypertension.   On 24-Oct-2019, the patient TREPROSTINIL DIOLAMIN (ORENITRAM) (Oral) dosage was changed to 5 milligram. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and TREPROSTINIL DIOLAMIN (ORENITRAM) (Oral) 1 milligram. On an unknown date, TREPROSTINIL DIOLAMIN (ORENITRAM) (Oral) dosage was changed to 17 milligram every eight hours. On an unknown date, the patient experienced VACCINATION COMPLICATION (It was reported that the patient got the COVID shot several months back and it affected another syndrome which she was having and). At the time of the report, VACCINATION COMPLICATION (It was reported that the patient got the COVID shot several months back and it affected another syndrome which she was having and) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that the patient got the COVID shot several months back and it affected another syndrome which she was having and it had been a little harder to get back to baseline.  No treatment drugs were reported.
Possible chicken pox, rash x 2 days vesicular rash with erythermatous halo consistent with varicella.
Leg cramps pain especially at night.  Worst with left leg. Headache and feeling heavy headedness. Lost of taste and small cramps on light side of tongue.
Sore throat, fatigue, headache, vomiting, diarrhea, weakness, paleness  symptoms very extreme -- almost went to ER.  Symptoms subsided by 11:00 PM -- eyes very red the next day.
Patient was given flu vaccine (R) vastus lateralis and patient waited 15m because no hx eggs. After 15 min RN assessed thigh had 2 1/2 inch x 1 1/4 inch red, raised welt where shot was given. Benadryl 15mg/5ml given orally @155pm after Dr assessed child. No respiratory symptoms. Patient discharged home with mom
sharp pains and burning in the right armpit; sharp pains and burning in the right armpit; diagnosed with shingles/ developed a rash; off label use; Product use for unapproved combination; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 at 08:30 as dose number unknown (booster), single (Lot number: GH9702) at the age of 40 years intramuscular, in right arm for covid-19 immunisation; influenza vaccine (INFLUENZA), on 23Sep2022 as dose 1, single (Lot number: UT7744JA), in left arm for immunisation. The patient's relevant medical history included: "Sleep apnea" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (primary immunization series complete; manufacturer unknown), for COVID-19 immunisation. The following information was reported: PRODUCT USE ISSUE (non-serious) with onset 23Sep2022, outcome "unknown", described as "Product use for unapproved combination"; OFF LABEL USE (non-serious) with onset 23Sep2022, outcome "unknown"; HERPES ZOSTER (non-serious) with onset 27Sep2022, outcome "recovering", described as "diagnosed with shingles/ developed a rash"; AXILLARY PAIN (non-serious), BURNING SENSATION (non-serious) all with onset 27Sep2022, outcome "recovering" and all described as "sharp pains and burning in the right armpit". The events "sharp pains and burning in the right armpit" and "diagnosed with shingles/ developed a rash" required physician office visit. Therapeutic measures were taken as a result of axillary pain, burning sensation, herpes zoster.  Additional information: Other vaccine received in four weeks was "Dynavax, Inc," (not further specified) on16Sep2022 as dose 1, single (Lot number: 938793) in left arm. Within a few days of receiving the COVID booster in the patient's right arm, she began to experience sharp pains and burning in her right armpit. She developed a rash that would not respond to diphenhydramine hydrochloride (BENADRYL), hydrocortisone, or steroid cream. She went to the doctor and was diagnosed with shingles. Treatment received included valacyclovir (VALTREX) on 04Oct2022 and topical ointment.
Shortly after getting flu shot (R) arm became red and blotchy - spread to chest neck and face around 4 PM. After lunch came to RPh and he gave her 25 mg Diphenhydramine. Rash subsided 45 min after diphenhydramine given.
low grade fever; Felt aches the next day after shot 2 low grade fever; This spontaneous report from a contactable consumer (patient). A 55-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 11Mar2021 (Batch/Lot Number: En6206) (at the age of 55 years) as dose 2, single for covid-19 immunisation. Medical history included rheumatoid arthritis and known allergies: Sulfa from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 administered in Arm Left on 18Feb2021 08:00 AM (Batch/Lot Number: El9266) (at the age of 55 years) for covid-19 immunisation. There was no other vaccine in four weeks. The patient felt aches the next day after shot 2, and low grade fever, both on 12Mar2021 06:45 with outcome of recovered.  There was no treatment received for the events. Patient has no COVID prior vaccination and had not been tested for COVID post vaccination.  No follow-up attempts are possible. No further information is expected.
Approximately 6 months after receiving the vaccine, I developed an extracranial arteriovenous malformation on my left occiput. I know it was not there before because I had a CAT scan with contrast in 2019 and it was not noted.
At a busy clinic, 7 doses were accidentally drawn from the vial instead of 6. No adverse effect that we are aware of.  Will re-train on procedures to prevent error from occurring again.
The first 2 days after receiving vaccine, she noticed slight redness to the injection site but by the 3rd day, it was swollen and redness increased in size and was warm and sore to touch; she also developed cold symptoms (runny nose, sneezing, headache) like half of her workmates; it is now day 9 since receiving the vaccine and the redness has lessened and it is not as swollen anymore but still sore to touch.  She took some multi-symptom medication for the cold symptoms and applied ice packs to the swollen area in the L upper arm.  Symptoms have improved but not resolved.  She still has slight runny nose and congestion and the redness to the arm is still there.
This is a spontaneous report from a contactable consumer reporting for self. A 66-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: CDR00811854), via an unspecified route of administration on 19Jan2021 14:15 at single dose for COVID-19 immunization.  Medical history included depression, anxiety.  Concomitant medication included levothyroxine, atorvastatin calcium (ATORVA), hydrochlorothiazide; lisinopril. The patient experienced Nausea, throwing up 3 times on 19Jan2021 18:15. Outcome of events was recovering.
Experienced rash all over upper body one day after receiving booster, no itch, which went away in a couple of days. About 2 weeks later I am now experiencing chronic migrating urticaria. Very itchy.
Sudden onset blurred vision left eye on 8/21 at 2230. Went to ER and sent home. Expressive aphasia on awakening at 0730 on 8/22. Internal carotid dissection on left with clot. 2 stents placed. Expressive aphasia persists. J&J given on 8/5. No history of trauma. Doctors have no idea how this occurred.
Sudden Onset, bilateral tinnitus and hearing loss starting sometime between 2nd dose and booster.  I have been to a few different doctors who have prescribed decongestants, NSAIDS, and chiropractic adjustments - none of which have helped.